Back
Cellectar Biosciences Stock Price Chart
Former Chicago Pit Trader Exposes Shocking Trading Advantage:
See How to Target Up to 383% OVERNIGHT
Sell
44
CLRB
Cellectar Biosciences
Last Price:
2.11
Seasonality Move:
-15.64%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.
Cellectar Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Buy |
| 20-day SMA: | 2.13 | Sell |
| 50-day SMA: | 2.2 | Sell |
| 200-day SMA: | 2.99 | Sell |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.12 | Sell |
| 50-day EMA: | 2.26 | Sell |
| 200-day EMA: | 2.68 | Sell |
Cellectar Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 47.18 | Sell |
| Chaikin Money Flow: | -77885 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.05 - 2.17) | Sell |
| Bollinger Bands (100): | (2.12 - 3.1) | Sell |
Cellectar Biosciences Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
- Cellectar Biosciences share price is 2.11 while CLRB 8-day simple moving average is 2.11, which is a Buy signal.
- The stock price of CLRB is 2.11 while Cellectar Biosciences 20-day SMA is 2.13, which makes it a Sell.
- Cellectar Biosciences 50-day simple moving average is 2.20 while CLRB share price is 2.11, making it a Sell technically.
- CLRB stock price is 2.11 and Cellectar Biosciences 200-day simple moving average is 2.99, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
44
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a Sell
The current Cellectar Biosciences [CLRB] share price is $2.11. The Score for CLRB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
75.64M
Price in USD:
2.11
Share Volume:
233.66K
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
1.82
Sell
44
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?
The Cellectar Biosciences stock price is 2.11 USD today. -
Will CLRB stock go up or go down?
Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Cellectar Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
- Cellectar Biosciences share price is 2.11 while CLRB 8-day exponential moving average is 2.11, which is a Sell signal.
- The stock price of CLRB is 2.11 while Cellectar Biosciences 20-day EMA is 2.12, which makes it a Sell.
- Cellectar Biosciences 50-day exponential moving average is 2.26 while CLRB share price is 2.11, making it a Sell technically.
- CLRB stock price is 2.11 and Cellectar Biosciences 200-day simple moving average is 2.68, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
- CLRB Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Cellectar Biosciences is a Sell
- Cellectar Biosciences Relative Strength Index (RSI) is 47.18, which suggest Cellectar Biosciences is oversold
- The Bollinger Bands (25) for Cellectar Biosciences is (2.05 - 2.17), which suggest Cellectar Biosciences is a Sell
- The Bollinger Bands (100) for Cellectar Biosciences is (2.12 - 3.1), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.